TINNESTA - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 87739259
Serial Number
87739259
Word Mark
TINNESTA
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-07-26
Filing Date
2017-12-31
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-04-24
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
LEVINE, HOWARD B
Statements
Goods and Services
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Nutraceuticals for use as a dietary supplement; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of the endocannabinoid; Human vaccine preparations; Oral vaccine preparations
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-16
Primary Code
005
Correspondences
Name
Samuel Fifer
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-01-03NEW APPLICATION ENTERED IN TRAM
2018-01-16NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-03-22ASSIGNED TO EXAMINER
2018-03-22APPROVED FOR PUB - PRINCIPAL REGISTER
2018-04-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-04-24PUBLISHED FOR OPPOSITION
2018-04-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-06-19NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-12-19TEAS EXTENSION RECEIVED
2018-12-19EXTENSION 1 FILED
2018-12-19EXTENSION 1 GRANTED
2018-12-21NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-01-17TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-01-17ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-05-22TEAS EXTENSION RECEIVED
2019-05-22EXTENSION 2 FILED
2019-05-22EXTENSION 2 GRANTED
2019-05-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-05-22TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-10-15TEAS EXTENSION RECEIVED
2019-10-15EXTENSION 3 FILED
2019-10-15EXTENSION 3 GRANTED
2019-10-17NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-06-08TEAS EXTENSION RECEIVED
2020-06-08EXTENSION 4 FILED
2020-06-08EXTENSION 4 GRANTED
2020-06-10NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-12-08TEAS EXTENSION RECEIVED
2020-12-21CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-12-08EXTENSION 5 FILED
2021-01-04EXTENSION 5 GRANTED
2021-01-05NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-07-26ABANDONMENT - NO USE STATEMENT FILED
2021-07-26ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED